Inventor · disambiguated record
Yves Levy
Also filed as: LEVY YVES
18 granted patents·18 pending applications·195 citations·filing 1979–2022
93Inventor score
Files withINST NAT SANTE RECH MED16BAYLOR RES INSTITUTE3ZURAWSKI GERARD3INSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE2LEVY YVES2
Top patents by PatentIndex Score
36 records- 0197US8518410B2Fusion protein with HIV antigenZURAWSKI GERARD·Filed 2010·Granted Aug 27, 2013·50 cites·22 claims
- 0296US8961991B2Anti-CD40 targeted fusion proteinsZURAWSKI GERARD·Filed 2010·Granted Feb 24, 2015·48 cites·18 claims
- 0395US9416186B2Antigen presenting cell targeted anti-viral vaccinesZURAWSKI GERARD·Filed 2013·Granted Aug 16, 2016·27 cites·9 claims
- 0492US11219683B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2020·Granted Jan 11, 2022·2 cites·14 claims
- 0591US10610585B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2018·Granted Apr 7, 2020·3 cites·25 claims
- 0688US10662253B2Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activityINST NAT SANTE RECH MED·Filed 2015·Granted May 26, 2020·5 cites·6 claims
- 0785US10988544B2Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptidesBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 27, 2021·1 cites·11 claims
- 0884US9862927B2Dendritic cell vaccinesBANCHEREAU JACQUES F·Filed 2011·Granted Jan 9, 2018·7 cites·13 claims
- 0983US10722572B2Methods and compositions for treating and preventing HIVINST NAT SANTE RECH MED·Filed 2019·Granted Jul 28, 2020·1 cites·29 claims
- 1081US11685792B2Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activityINST NAT SANTE RECH MED·Filed 2020·Granted Jun 27, 2023·1 cites·9 claims
- 1179US9885017B2Compositions and methods to immunize against hepatitis C virusBAYLOR RES INSTITUTE·Filed 2014·Granted Feb 6, 2018·3 cites·14 claims
- 1279US4275302AMethod and device for converting thermal images into secondary images, e. g. visible imagesANVAR·Filed 1979·Granted Jun 23, 1981·40 cites·31 claims
- 1375US2021221904A1Fusion proteins comprising an anti-cd40 antibody and hiv antigenic peptidesBAYLOR RES INSTITUTE·Filed 2021·Application pending·0 cites
- 1469US7678584B2Method for characterizing a surface, and device thereforINST OPTIQUE THEORIQUE ET APPL·Filed 2006·Granted Mar 16, 2010·6 cites·11 claims
- 1565US2025025548A1Universal sarbecovirus vaccinesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1659US2024124532A1Chlamydia trachomatis antigenic polypeptides and uses thereof for vaccine purposesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 1759US2024010739A1Antibodies conjugated or fused to the receptor-binding domain of the sars-cov-2 spike protein and uses thereof for vaccine purposesINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1859US2010303828A1Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells ActivityINST NAT SANTE RECH MED·Filed 2009·Application pending·0 cites
- 1958US2024131138A1Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cellsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 2056US2023212231A1Severe acute respiratory syndrome coronavirus 2 (sars-cov-2) polypeptides and uses thereof for vaccine purposesINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 2156US2023183366A1Recombinant proteins with ox40 activating propertiesINSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE·Filed 2021·Application pending·0 cites
- 2255US2015299329A1Antigen presenting cell targeted vaccinesBAYLOR RES INST·Filed 2015·Application pending·0 cites
- 2354US8932599B2Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccinesLEVY YVES·Filed 2009·Granted Jan 13, 2015·0 cites·11 claims
- 2454US2022018853A1Use of gilz as a biomarker in sepsisINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 2551US2012301465A1Compositions and methods to immunize against hepatitis c virusDUTARTRE HELENE·Filed 2012·Application pending·0 cites
- 2649US7998726B2Method for fixing a protein on a pyrrole-based polymer and use thereof for making a sensorCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2003·Granted Aug 16, 2011·1 cites·17 claims
- 2748US9804172B2Soluble ST2 as a marker for risk of mortality in HIV-infected subjectsINST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)·Filed 2012·Granted Oct 31, 2017·0 cites·6 claims
- 2848US2023034677A1Novel immunotherapies targeting pd-1 with anti-pd-1/il-15 immunocytokinesINSERM INSTITUT NATIONAL DE LA SANTE ET LA RECH MEDICALE·Filed 2020·Application pending·0 cites
- 2946US2013157290A1Soluble st2 as a marker for diseaseLEVY YVES·Filed 2011·Application pending·0 cites
- 3043US2012244155A1Dendritic Cells (DCs) Targeting for Tuberculosis (TB) VaccineLECINE PATRICK·Filed 2012·Application pending·0 cites
- 3141US2015276760A1Method for Screening a Compound Capable of Inhibiting the Notch1 Transcriptional ActivityINST NAT SANTE RECH MED·Filed 2012·Application pending·0 cites
- 3240US2022249426A1Inhibitors of the sting pathway for the treatment of hidradenitis suppurativaINSERM INSTITUT NAT DE LA SANTE ET DE LA RECHERCH MEDICALE·Filed 2020·Application pending·0 cites
- 3337US10724095B2Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infectionsINST NAT SANTE RECH MED·Filed 2016·Granted Jul 28, 2020·0 cites·9 claims
- 3436US2004235177A1Method for characterising a surface, and device thereforFiled 2001·Application pending·0 cites
- 3535US10548980B2P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infected with human immunodeficiency virus (HIV)INST NAT SANTE RECH MED·Filed 2017·Granted Feb 4, 2020·0 cites·4 claims
- 3635US2015140043A1Immunomodulatory methods using notch agonistsINST NAT SANTE RECH MED·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yves Levy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →